BioNTech SE Net Foreign Exchange Loss
BioNTech SE (BNTX) reported Net Foreign Exchange Loss of EUR 48.40 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:NetForeignExchangeLoss · last filed 2026-03-10
| Period end | Net Foreign Exchange Loss 12 month | Net Foreign Exchange Loss 12 month as first filed |
|---|---|---|
| 2025-12-31 | 48.40M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 0.00 EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 15.90M EUR 20-F · filed 2026-03-10 | 16.00M EUR 20-F · filed 2024-03-20 |
| 2022-12-31 | 0.00 EUR 20-F · filed 2025-03-10 | |
| 2021-12-31 | 0.00 EUR 20-F · filed 2024-03-20 | |
| 2020-12-31 | 42.60M EUR 20-F · filed 2023-03-27 | 42.61M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 0.00 EUR 20-F/A · filed 2022-10-26 | |
| 2017-12-31 | 25.95M EUR 20-F · filed 2020-03-31 |